The genes associated with this immune signature were characteristic of a strong cytotoxic response, involving CD8+ T-cells, but also other actors of anti-tumor immunity (γδ-T-cells, NKG2D+ cells, dendritic-cells, B-cells ...). This evidence concerns the gene KLRK1 and neoplasm.